Purdue Opioid Settlement Contingent on DOJ Probes
News2019-10-10
2 Views
OxyContin maker Purdue Pharma LP’s plan to turn over its operations to creditors and see its owners, the Sacklers, exit the opioid business is contingent on resolving several criminal and civil probes by the U.S. Justice Department.
Source: The Crime Report ( TheCrimeReport.org )
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
FSD Pharma (Nasdaq: HUGE) Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis
